한글목차

개요

세계 부인과 장비 시장은 2023년 154억 달러, 2031년에는 269억 달러에 달할 것으로 예상되며, 2024-2031년의 예측 기간 동안 6.8%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

부인과 장비는 여성 생식 기관과 관련된 상태를 진단, 치료 및 관리하는 데 사용되는 의료 도구 및 장비입니다. 예방과 치료의 두 가지 접근 방식을 모두 지원하며, 산모 관리, 암 검진, 불임 치료 등 다양한 용도로 사용됩니다. 거울이나 질경과 같은 기본적인 도구부터 로봇 수술 시스템이나 초음파 진단 장비와 같은 첨단 기술에 이르기까지 여성의 건강 결과와 삶의 질을 향상시킵니다.

시장 역학 :

성장 촉진요인과 저해요인

산부인과 장비의 발전

첨단 복강경 로봇 수술은 부인과에서 자궁 적출, 자궁근종 제거, 자궁내막증 절제, 골반 장기 탈수복 등의 수술에 사용되고 있습니다. 높은 정밀도로 인해 주변 조직과 장기를 손상시킬 위험이 적고 합병증이 적습니다. 절개창이 작아 수술 후 통증, 입원 기간, 회복 시간이 단축됩니다. 향상된 가시성과 조작성은 자궁내막 이식 및 자궁근종 제거에 대한 외과의사의 능력을 향상시켜 수술의 성공률을 높입니다.

예를 들어, 2024년 4월 프랑스의 대형 민간 병원 그룹인 ELSAN의 일부인 Franche-Comte Polyclinic과 협동 로봇의 선구자인 프랑스계 미국인 Moon Surgical은 부인과 복강경 수술에 마에스트로 시스템을 임상적으로 사용한다고 발표했습니다. 부인과 복강경 수술에 임상 사용되고 있다고 발표했습니다.

엄격한 규제 요건

세계 부인과 기기 시장은 엄격한 규제 요건, 높은 비용, 숙련된 의료 전문가 부족, 문화적 및 사회적 낙인, 합병증 및 위험 등의 문제에 직면해 있습니다. 이러한 요인들은 특히 저소득 지역 시장 성장을 저해하고 고급 부인과 수술에 대한 접근성을 제한할 수 있습니다. 또한, 문화적, 사회적 편견은 인식과 이용의 장벽이 될 수 있으며, 합병증과 위험은 환자와 의료 서비스 제공업체가 꺼려하는 요인으로 작용할 수 있습니다.

목차

제1장 조사 방법과 조사 범위

제2장 정의와 개요

제3장 주요 요약

제4장 시장 역학

• 영향요인
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 영향 분석

제5장 산업 분석

• Porter의 Five Forces 분석
• 공급망 분석
• 가격 분석
• 규제 분석
• 특허 분석
• PESTLE 분석
• SWOT 분석
• DMI의 견해

제6장 제품 유형별

• 진단 기기
• 외과용 기기
• 모니터링 기기

제7장 용도별

• 산과
• 부인과
• 불임 치료
• 기타

제8장 최종사용자별

• 병원
• 클리닉
• 진단 실험실
• 기타

제9장 지역별

• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타 유럽
• 남미
  • 브라질
  • 아르헨티나
  • 기타 남미
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 기타 아시아태평양
• 중동 및 아프리카

제10장 경쟁 구도

• 경쟁 시나리오
• 시장 현황/점유율 분석
• 인수합병(M&A) 분석

제11장 기업 개요

• B. Braun Melsungen AG
  • 기업 개요
  • 제품 포트폴리오와 설명
  • 재무 개요
  • 주요 발전
• Medtronic Plc
• Cooper Surgical, Inc
• Richard Wolf GmbH
• Hologic, Inc
• Boston Scientific Corporation
• Stryker Corporation
• Karl Storz GmbH & Co. KG
• Ethicon, Inc
• MedGyn Products

제12장 부록

영문목차

Overview

Global Gynecological Devices Market reached US$ 15.4 billion in 2023 and is expected to reach US$ 26.9 billion by 2031, growing at a CAGR of 6.8% during the forecast period 2024-2031

Gynecological devices are medical tools and equipment used to diagnose, treat, and manage conditions related to the female reproductive system. They support both preventive and therapeutic approaches, and are used in various applications such as prenatal care, cancer screening, and infertility treatments. From basic tools like speculums and colposcopes to advanced technologies like robotic surgical systems and ultrasound machines, they enhance women's health outcomes and quality of life.

Market Dynamics: Drivers & Restraints

Advancements in the gynecological devices

Advanced laparoscopic robotic surgery is used in gynaecology for procedures like hysterectomies, myomectomies, endometriosis resection, and pelvic organ prolapse repairs. Its precision reduces the risk of damage to surrounding tissues and organs, resulting in fewer complications. Smaller incisions reduce postoperative pain, hospital stays, and recovery times. The enhanced visualisation and maneuverability improve the surgeon's ability to remove endometrial implants and fibroids, increasing procedure success rates.

For instance, in April 2024, the Franche-Comte Polyclinic, part of ELSAN, the leading private hospital group in France, and Moon Surgical, a French-American pioneer in collaborative robotics, announced that the Maestro System is now being used clinically in gynecological laparoscopic procedures.

Stringent regulatory requirements

The global gynecological devices market faces challenges such as stringent regulatory requirements, high costs, shortage of skilled healthcare professionals, cultural and social stigmas, and complications and risks. These factors can hinder the growth of the market, especially in low-income regions, and limit access to advanced gynecological procedures. Additionally, cultural and social stigmas can create barriers to awareness and usage, and complications and risks may lead to reluctance among patients and healthcare providers.

Segment Analysis

The global gynecological devices market is segmented based on product type, application, end user and region.

The diagnostic devices from the product type segment accounted for approximately 41.3% of the gynecological devices market share

The diagnostic devices from the product type segment accounted for approximately 41.3%. Diagnostic devices, such as ultrasound systems, colposcopes, hysteroscopes, and mammography machines, are vital in the global gynecological devices market for early detection, diagnosis, and monitoring of various conditions like cervical cancer, ovarian cysts, endometriosis, and other reproductive health disorders. Advancements in imaging technologies have improved the accuracy and efficiency of these diagnostic tools, leading to better patient outcomes and promoting preventive care and treatment planning.

For instance, in Septembe 2024, Samsung Medison, a global medical equipment company, will showcase its HERA Z20 ultrasound system at the 34th annual ISUOG World Congress 2024 in Budapest. The premium ultrasound system, which is considered the most important in the field of OB&GYN ultrasound, features advanced AI diagnostic assistance features to improve women's and fetuses' health. The Live ViewAssist feature provides real-time diagnosis location, reduces measurement time, and increases accuracy by automatically classifying cross sections and providing measurement results for the entire quarter of OB&GYN.

Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to novel product launches, FDA approvals, presence of a well-established healthcare infrastructure, rising levels of awareness regarding the availability of diagnostic tests & treatments, and developed reimbursement coverage.

For instance, in September 2022, Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the market launch of the Guardenia Contained Extraction System. Guardenia is the latest innovation in their contained tissue extraction product portfolio for gynecological procedures and is manufactured by Advanced Surgical Concepts (ASC) Ltd. of Bray, Ireland.

Market Segmentation

By Product Type

• Diagnostic Devices
• Surgical Devices
• Monitoring Devices

By Application

• Obstetrics
• Gynecology
• Fertility
• Others

By End User

• Hospitals
• Clinics
• Diagnostic Laboratories
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include B. Braun Melsungen AG, Medtronic Plc, Cooper Surgical, Inc, Richard Wolf GmbH, Hologic, Inc, Boston Scientific Corporation, Stryker Corporation, Karl Storz GmbH & Co. KG, Ethicon, Inc, MedGyn Products among others.

Key Developments

• In April 2024, GE HealthCare announced that it launched the Voluson Signature 20 and 18 ultrasound systems for women's health imaging applications. Chicago-based GE HealthCare designed the systems to integrate AI, advanced tools and an ergonomic design. They speed exam time for clinicians while delivering a clearer picture of various conditions impacting women's health. The latest systems combine high-performance hardware with flexible, scalable software to help increase confidence in diagnostic and treatment decisions.

Why Purchase the Report?

• To visualize the global gynecological devices market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the gynecological devices market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global gynecological devices market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Application
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Advancements in the gynecological devices
    • 4.1.1.2. Rise in the prevalence of gynecological diseases
  • 4.1.2. Restraints
    • 4.1.2.1. Stringent regulatory requirements
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Patent Analysis
• 5.6. PESTLE Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Diagnostic Devices*
  • 6.2.1. Introduction
• 6.3. Surgical Devices
• 6.4. Monitoring Devices

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
• 7.2. Market Attractiveness Index, By Application
• 7.3. Obstetrics*
  • 7.3.1. Introduction
  • 7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.4. Gynecology
• 7.5. Fertility
• 7.6. Others

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.1.2. Market Attractiveness Index, By End User
• 8.2. Hospitals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Clinics
• 8.4. Diagnostic Laboratories
• 8.5. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. UK
    • 9.3.6.3. France
    • 9.3.6.4. Italy
    • 9.3.6.5. Spain
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. B. Braun Melsungen AG*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Medtronic Plc
• 11.3. Cooper Surgical, Inc
• 11.4. Richard Wolf GmbH
• 11.5. Hologic, Inc
• 11.6. Boston Scientific Corporation
• 11.7. Stryker Corporation
• 11.8. Karl Storz GmbH & Co. KG
• 11.9. Ethicon, Inc
• 11.10. MedGyn Products

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us